Inhibrx
INBX
INBX
135 hedge funds and large institutions have $855M invested in Inhibrx in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 138 → 135 (-3)
15% less capital invested
Capital invested by funds: $1.01B → $855M (-$156M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
135
Holding in Top 10
2
Calls
$24.8M
Puts
$1.13M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$13M | |
| 3 | +$9.27M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$7.86M |
| 5 |
Morgan Stanley
New York
|
+$7.07M |
Top Sellers
| 1 | -$25.6M | |
| 2 | -$14.8M | |
| 3 | -$7.27M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$6.92M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$6.6M |
